Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

248 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Paclitaxel/carboplatin/etoposide versus gemcitabine/irinotecan in the first-line treatment of patients with carcinoma of unknown primary site: a randomized, phase III Sarah Cannon Oncology Research Consortium Trial.
Hainsworth JD, Spigel DR, Clark BL, Shipley D, Thompson DS, Farley C, West-Osterfield K, Lane CM, Cescon T, Bury MJ, Greco FA. Hainsworth JD, et al. Among authors: spigel dr. Cancer J. 2010 Jan-Feb;16(1):70-5. doi: 10.1097/PPO.0b013e3181c6aa89. Cancer J. 2010. PMID: 20164695 Clinical Trial.
Single-agent gefitinib in patients with untreated advanced non-small-cell lung cancer and poor performance status: a Minnie Pearl Cancer Research Network Phase II Trial.
Spigel DR, Hainsworth JD, Burkett ER, Burris HA, Yardley DA, Thomas M, Jones SF, Dickson NR, Scullin DC, Bradof JE, Rubinsak JR, Brierre JE, Greco FA. Spigel DR, et al. Clin Lung Cancer. 2005 Sep;7(2):127-32. doi: 10.3816/CLC.2005.n.028. Clin Lung Cancer. 2005. PMID: 16179100 Clinical Trial.
Paclitaxel/carboplatin/etoposide versus paclitaxel/topotecan for extensive-stage small cell lung cancer: a Minnie Pearl Cancer Research Network randomized, prospective phase II trial.
Greco FA, Thompson DS, Morrissey LH, Erland JB, Burris HA 3rd, Spigel DR, Joseph G, Corso SW, Spremulli E, Hainsworth JD. Greco FA, et al. Among authors: spigel dr. Oncologist. 2005 Oct;10(9):728-33. doi: 10.1634/theoncologist.10-9-728. Oncologist. 2005. PMID: 16249353 Free article. Clinical Trial.
Weekly docetaxel/estramustine phosphate in patients with increasing serum prostate- specific antigen levels after primary treatment for prostate cancer: a phase II trial of the Minnie Pearl Cancer Research Network.
Hainsworth JD, Meluch AA, Spigel DR, Yost K, Meng C, Greco FA. Hainsworth JD, et al. Among authors: spigel dr. Clin Genitourin Cancer. 2006 Mar;4(4):287-92. doi: 10.3816/CGC.2006.n.009. Clin Genitourin Cancer. 2006. PMID: 16729913 Clinical Trial.
248 results